Skip to main content Skip to search Skip to main navigation
 Get a free Melatonin Spray with purchases over €100  Get a free Melatonin Spray with purchases over €100 X
Menu
Premium Nahrungsergänzungsmittel | artgerecht

BRCA2 – Gene, Mutation & Cancer Risk

BRCA2 is a human tumor suppressor gene. Mutations in this gene significantly increase the risk of breast, ovarian, and other cancers.

Regular tips about health Regular tips about health
Lexicon Navigation

Things worth knowing about "BRCA2"

BRCA2 is a human tumor suppressor gene. Mutations in this gene significantly increase the risk of breast, ovarian, and other cancers.

What is BRCA2?

BRCA2 (Breast Cancer Gene 2) is a tumor suppressor gene located on chromosome 13. It encodes a protein that plays a critical role in the repair of DNA double-strand breaks. When functioning normally, it protects cells from uncontrolled growth and cancer development. When a mutation is present in the BRCA2 gene, this protective function is impaired, significantly increasing the risk of certain cancers.

Function of the BRCA2 Gene

The BRCA2 protein is a key component of the homologous recombination pathway of DNA repair. It interacts with the protein RAD51 and guides it to sites of DNA damage to facilitate repair. Without functional BRCA2 activity, DNA damage cannot be correctly resolved, leading to genomic instability and ultimately to tumor formation.

BRCA2 Mutations and Cancer Risks

Mutations in the BRCA2 gene are inherited in an autosomal dominant pattern, meaning that a single altered copy of the gene is sufficient to significantly increase the risk of certain cancers. The most commonly associated conditions include:

  • Breast cancer: The lifetime risk for breast cancer in female BRCA2 mutation carriers is approximately 45–85 %. Men with a BRCA2 mutation also face an elevated risk of around 6–8 %.
  • Ovarian cancer: The risk is approximately 10–30 %, compared to 1–2 % in the general population.
  • Prostate cancer: Men with a BRCA2 mutation have a significantly elevated risk of aggressive prostate cancer.
  • Pancreatic cancer: The risk is elevated compared to the general population.
  • Melanoma: A slightly increased risk of malignant melanoma has also been reported.

Diagnosis and Genetic Testing

A BRCA2 mutation is diagnosed through molecular genetic analysis of a blood or saliva sample. Testing is recommended for individuals with:

  • A personal or family history of breast or ovarian cancer at a young age
  • Multiple cancer diagnoses within the family
  • Male breast cancer in the family
  • Membership in ethnic groups with a higher mutation prevalence (e.g., Ashkenazi Jews)

Before and after genetic testing, genetic counseling should be provided to help interpret results and offer psychosocial support.

Prevention and Surveillance

For individuals with a confirmed BRCA2 mutation, several preventive options are available:

  • Enhanced screening: Regular mammograms, breast MRI scans, gynecological check-ups, and PSA testing for men.
  • Risk-reducing surgery: Prophylactic mastectomy (removal of breast tissue) and/or salpingo-oophorectomy (removal of fallopian tubes and ovaries) can substantially reduce cancer risk.
  • Chemoprevention: In selected cases, medications such as tamoxifen may be considered to reduce breast cancer risk.

Treatment of BRCA2-Associated Cancers

Knowledge of a BRCA2 mutation significantly influences treatment decisions. PARP inhibitors (e.g., olaparib, niraparib) are an important drug class used specifically for BRCA2-mutated tumors, as these tumors are particularly sensitive to this type of therapy. Platinum-based chemotherapy agents also show increased effectiveness in BRCA2-mutated cancers.

References

  1. Wooster R, Weber BL. Breast and ovarian cancer. New England Journal of Medicine, 2003; 348(23):2339–2347.
  2. National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic. Version 2024.
  3. Kuchenbaecker KB et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA, 2017; 317(23):2402–2416.
artgerecht

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.

Verwandte Produkte

floral lactoferrin cln mundflora lutschtabletten?ts=1781276101

Average rating of 4.96 out of 5 stars

Floral

For Healthy Oral Flora & Dental Care

Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
Sugar free
Lab tested
Non-GMO
Cologne List
Lactose free
Tooth friendly
GMP Quality
Clinical proofed
Pure CLN
30 lozenges
Regular price: €22.90
Product Quantity: Enter the desired amount or use the buttons to increase or decrease the quantity.
lactoferrin 60 eisenbinder transporter kuhmilch?ts=1758111262

Average rating of 4.85 out of 5 stars

Lactoferrin

For your universal protection

As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
UV glass
Lab tested
Non-GMO
No additives
Cologne List
Lactose free
[siehe Varianten]
Regular price: €59.90
natural iron supplement premium plantderived mineralcomplex?ts=1751927698

Average rating of 4.94 out of 5 stars

Natural Iron

For your iron balance

Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
UV glass
Lab tested
Non-GMO
No additives
Cologne List
Gluten free
Lactose free
100% vegetarian fermentation
30 Capsules
30 Capsules
Regular price: €35.90
Product Quantity: Enter the desired amount or use the buttons to increase or decrease the quantity.